Effect of continuous positive airway pressure on c-reactive protein levels in sleep apnea: A meta-analysis

Otolaryngology - Head and Neck Surgery (United States)

Volumn 147, Issue 3, 2012, Pages 423-433

  Friedman, Michael ^a,b,e   Samuelson, Christian G ^b   Hamilton, Craig ^b   Fisher, Michelle ^b   Kelley, Kanwar ^b   Joseph, Ninos J ^b   Wang, Pa Chun ^c   Lin, Hsin Ching ^d  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b ADVOCATE ILLINOIS MASONIC MEDICAL CENTER   (United States)

^c CATHAY GENERAL HOSPITAL   (Taiwan)

^d CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^e Advanced Center for Specialty Care   (United States)

Author keywords

C reactive protein; continuous positive airway pressure; CPAP; CRP; obstructive sleep apnea hypopnea syndrome; sleep apnea

Indexed keywords

C REACTIVE PROTEIN;

BODY MASS; CARDIOVASCULAR RISK; CASE CONTROL STUDY; COCHRANE LIBRARY; EFFECT SIZE; HUMAN; MEDLINE; META ANALYSIS; POSITIVE END EXPIRATORY PRESSURE; PROTEIN BLOOD LEVEL; PUBLISHING; REVIEW; RISK REDUCTION; SENSITIVITY ANALYSIS; SLEEP DISORDERED BREATHING; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; STUDY DESIGN; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

ADULT; BODY MASS INDEX; C-REACTIVE PROTEIN; CLINICAL TRIALS AS TOPIC; CONTINUOUS POSITIVE AIRWAY PRESSURE; ENDPOINT DETERMINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; SLEEP APNEA, OBSTRUCTIVE;

EID: 84870415278     PISSN: 01945998     EISSN: 10976817     Source Type: Journal    
DOI: 10.1177/0194599812451840     Document Type: Review

References (29)

1. Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest. 2003 ; 111: 1805-1812 (Pubitemid 38057722)
2. Fanfulla F, Grassi M, Taurino AE, D'Artavilla Lupo N, Trentin R. The relationship of daytime hypoxemia and nocturnal hypoxia in obstructive sleep apnea syndrome. Sleep. 2008 ; 31: 249-255 (Pubitemid 351536527)
3. Nieto FJ, Young TB, Lind BK, et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA. 2000 ; 283: 1829-1836 (Pubitemid 30207619)
4. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med. 2000 ; 342: 1378-1384 (Pubitemid 30262394)
5. Haack M, Sanchez E, Mullington JM. Elevated inflammatory markers in response to prolonged sleep restriction are associated with increased pain experience in healthy volunteers. Sleep. 2007 ; 30: 1145-1152 (Pubitemid 47378957)
6. Punjabi NM, Beamer BA. C-reactive protein is associated with sleep disordered breathing independent of adiposity. Sleep. 2007 ; 30: 29-34 (Pubitemid 46095380)
7. Kapsimalis F, Varouchakis G, Manousaki A, et al. Association of sleep apnea severity and obesity with insulin resistance, C-reactive protein, and leptin levels in male patients with obstructive sleep apnea. Lung. 2008 ; 186: 209-217
8. Shamsuzzaman AS, Winnicki M, Lanfranchi P, et al. Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation. 2002 ; 105: 2462-2464 (Pubitemid 34568964)
9. Chung S, Yoon IY, Shin YK, et al. Endothelial dysfunction and C-reactive protein in relation with the severity of obstructive sleep apnea syndrome. Sleep. 2007 ; 30: 997-1001 (Pubitemid 47221900)
10. Saletu M, Nosiska D, Kapfhammer G, et al. Structural and serum surrogate markers of cerebrovascular disease in obstructive sleep apnea (OSAHS): association of mild OSAHS with early atherosclerosis. J Neurol. 2006 ; 253: 746-752 (Pubitemid 43980146)
11. Ye J, Liu H, Li Y, Liu X, Zhu JM. Increased serum levels of C-reactive protein and matrix metalloproteinase-9 in obstructive sleep apnea syndrome. Chin Med J (Engl). 2007 ; 120: 1482-1486 (Pubitemid 47496582)
12. Zouaoui Boudjeltia K, Van Meerhaeghe A, Doumit S, et al. Sleep apnoea-hypopnoea index is an independent predictor of high-sensitivity C-reactive protein elevation. Respiration. 2006 ; 73: 243-346
13. Lui MM, Mak HK, Xu A, et al. C-reactive protein is associated with obstructive sleep apnea independent of visceral obesity. Chest. 2009 ; 135: 950-956
14. Friedman M Sleep Apnea and Snoring: Surgical and Non-Surgical Therapy. Philadelphia, PA: Saunders ; 2009 :
15. Kohler M, Pepperell JC, Packwood KL, et al. Effects of continuous positive airway pressure on systemic inflammation in patients with moderate to severe obstructive sleep apnoea: a randomised controlled trial. Thorax. 2009 ; 64: 67-73
16. Carneiro G, Togeiro SM, Ribeiro-Filho FF, et al. Continuous positive airway pressure therapy improves hypoadiponectinemia in severe obese men with obstructive sleep apnea without changes in insulin resistance. Metab Syndr Relat Disord. 2009 ; 7: 537-542
17. Dorkova Z, Petrasova D, Molcanyiova A, Popovnakova M, Tkacova R. Effects of continuous positive airway pressure on cardiovascular risk profile in patients with severe obstructive sleep apnea and metabolic syndrome. Chest. 2008 ; 134: 686-692
18. Drager LF, Bortolotto LA, Figueiredo AC, Krieger EM, Lorenzi GF. Effects of continuous positive airway pressure on early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med. 2007 ; 176: 706-712 (Pubitemid 47503079)
19. Drummond M, Winck J, Guimaraes J, Santos AC, Almeida J, Marques J. Long term effect of autoadjusting positive airway pressure on C-reactive protein and interleukin-6 in men with obstructive sleep apnoea syndrome. Arch Bronconeumol. 2009 ; 45: 577-584
20. Iesato K, Tatsumi K, Saibara T, et al. Decreased lipoprotein lipase in obstructive sleep apnea syndrome. Circ J. 2007 ; 71: 1293-1298 (Pubitemid 47195349)
21. Yokoe T, Minoguchi K, Matsuo H, et al. Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation. 2003 ; 107: 1129-1134 (Pubitemid 36297204)
22. Ishida K, Kato Y, Yanagihara K, et al. Appropriate use of nasal continuous positive airway pressure decreases elevated C-reactive protein in patients with obstructive sleep apnea. Chest. 2009 ; 136: 125-129
23. Patruno V, Costantino G, Murgia R, Selmi C, Malliani A, Montano N. Fixed and autoadjusting continuous positive airway pressure treatments are not similar in reducing cardiovascular risk factors in patients with obstructive sleep apnea. Chest. 2007 ; 131: 1393-1399 (Pubitemid 46762344)
24. Steiropoulos P, Tsara V, Nena E, et al. Effect of continuous positive airway pressure treatment on serum cardiovascular risk factors in patients with obstructive sleep apnea-hypopnea syndrome. Chest. 2007 ; 132: 843-851
25. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986 ; 7: 177-188 (Pubitemid 17189972)
26. Ryan S, Nolan GM, Hannigan E, Cunningham S, Taylor C, McNicholas WT. Cardiovascular risk markers in obstructive sleep apnoea syndrome and correlation with obesity. Thorax. 2007 ; 62: 509-514 (Pubitemid 46910129)
27. Sharma SK, Mishra HK, Sharma H, et al. Obesity, and not obstructive sleep apnea, is responsible for increased serum hs-CRP levels in patients with sleep-disordered breathing in Delhi. Sleep Med. 2008 ; 9: 149-156
28. Rexrode KM, Pradhan A, Manson JE, Buring JE, Ridker PM. Relationship of total and abdominal adiposity with CRP and IL-6 in women. Ann Epidemiol. 2003 ; 13: 674-682 (Pubitemid 37346407)
29. Myers GL, Rifai N, Tracy RP, et al. CDC/AHA workshop on markers of inflammation and cardiovascular disease: application to clinical and public health practice: report from the laboratory science discussion group. Circulation. 2004 ; 110: 545-549